Ultimately, PHGDH embodies three cardinal paradoxes of cancer metabolism: a metabolic lifeline under stress that becomes a therapeutic liability; a promoter of primary tumorigenesis that may suppress metastasis; and an enzymatic workhorse moonlighting as an epigenetic regulator. The gene discussed is PHGDH; the disease is cancer.